But we said it throughout this guide, and well say it once more - we still dont know a ton about the full potential of AHK-Cu for hair growth
Based on the current stage of clinical development and estimated trial completion dates registered on ClinicalTrials.gov, a realistic earliest possible timeline might be considered as follows: 20252026: Completion of key phase 3 TRIUMPH trial data 20262027: Potential regulatory submission to the MHRA (and FDA/EMA in parallel) 20272028: Possible MHRA marketing authorisation, subject to satisfactory review 2028 onwards: NICE technology appraisal and potential NHS commissioning decision These timelines are speculative and depend on multiple variables, including trial outcomes, the completeness of the regulatory submission, MHRA review timelines, and NICE deliberations
Neuropharmacology 61(12):2028
Hence, it was conceivable that retatrutide could exert effects on force of contraction (FOC) or positive chronotropic effects (PCE) via any of these receptors
Berberine, by contrast, works through multiple pathways including AMPK activation and mitochondrial function, independently affecting glucose metabolism and lipid profiles without direct receptor activation